The effects of intra-articular tranexamic acid given intraoperatively and intravenous tranexamic acid given preoperatively on post surgical bleeding and transfusion rate post total knee arthroplasty

Authors

  • Aryo N. Triyudanto Department of Orthopaedy and Traumatology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta
  • Andri M.T. Lubis Department of Orthopaedy and Traumatology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta

DOI:

https://doi.org/10.13181/mji.v25i4.1502

Keywords:

blood transfusion, intravenous, intra-articular, postoperative bleeding, total drain, total knee replacement, tranexamic acid

Abstract

Background: Despite the advances in the design and fixation of implants in total knee replacement (TKR). the amount of postoperative bleeding is still an important issue that has not been resolved. This study aimed to measure the effectiveness of various tranexamic acid administration.

Methods: This was a randomized controlled trial study, held from August 2014 to February 2016 at Cipto Mangunkusumo Hospital, Jakarta. Twenty two patients having TKR were divided into three groups: the control group, the tranexamic acid intra-articular-intraoperative group, and the intravenous preoperative group. Intraoperative bleeding, haemoglobin (Hb) level on preoperative to five-day-post-surgery, total drain production, total blood tranfusion needed and the drain removal timing were recorded and compared. Numerical data were analyzed by using parametric and non-parametric test, depended on the normality of the data.

Results: The amount of blood transfusion needed in both the intra-articular group (200±SD 100 mL) and the intravenous group (238±SD 53 mL) were significantly different compared to those in the control group (1,016±SD 308.2 mL) (p=0.001). Meanwhile, there was no significant difference between the amount of blood transfusion needed in the intra-articular group and the intravenous group. Total drain production in the intra-articular group (328±SD 193 mL) and intravenous group (391±SD 185 mL) was significantly different compared to the control group (652±SD 150 mL) (p=0.003). No significant difference between the levels of both preoperative and postoperative haemoglobin, the amount of intraoperative bleeding, and the duration of drain usage.

Conclusion: Intravenous and intra-articular tranexamic acid effectively decreased transfusion volume and drain production in patients undergoing TKR.

Downloads

Download data is not yet available.

References

Civinini R, Nistri L, Martini C, Redl B, Ristori G, Innocenti M. Growth factors in the treatment of early osteoarthritis. Clin Cases Miner Bone Metab. 2013;10(1):26–9. https://doi.org/10.11138/ccmbm/2013.10.1.026

Flanigan DC, Harris JD, Trinh TQ, Siston RA, Brophy RH. Prevalence of chondral defects in athletes' knees: a systematic review. Med Sci Sports Exerc. 2010;42(10):1795–801. https://doi.org/10.1249/MSS.0b013e3181d9eea0

Molloy DO, Archbold HA, Ogonda L, McConway J, Wilson RK, Beverland BE. Comparison of topical fibrin spray and tranexamic acid on blood loss after total knee replacement: a prospective randomized control trial. J Bone Joint Surg Br. 2007;89(3):306–9. https://doi.org/10.1302/0301-620X.89B3.17565

Turpie AG, Lassen MR, Davidson BL, Bauer KA, Gent M, Kwong LM, et al. Rivaroxaban versus enoxaparin for thrombophylaxis after total knee arthroplasty (RECORD4): a randomised trial. Lancet. 2009;373(9676):1673–80. https://doi.org/10.1016/S0140-6736(09)60734-0

Hame SL, Alexander RA. Knee osteoarthritis in women. Curr Rev Musculoskelet Med. 2013;6(2):182–7 https://doi.org/10.1007/s12178-013-9164-0

Heidari B. Knee osteoarthritis prevalence, risk factors, pathogenesis and features: Part I. Casp J Intern Med. 2011;2(2):205–12.

Karaaslan F, Karao?lu S, Mermerkaya MU, Baktir A. Reducing blood loss in simultaneous bilateral total knee arthroplasty: combined intravenous-intra-articular tranexamic acid administration. A prospective randomized controlled trial. Knee. 2015;22(2):131–5. https://doi.org/10.1016/j.knee.2014.12.002

Iwai T, Tsuji S, Tomita T, Sugamoto K, Hideki Y, Hamada M. Repeat-dose intravenous tranexamic acid further decreases blood loss in total knee arthroplasty. Int Orthop. 2013;37(3):441–5. https://doi.org/10.1007/s00264-013-1787-7

Chen JY, Rikhraj IS, Zhou Z, Tay DK, Chin PL, Chia SL, et al. Can tranexamic acid and hydrogen peroxide reduce blood loss in cemented total knee arthroplasty? Arch Orthop Trauma Surg. 2014;134(7):997–1002. https://doi.org/10.1007/s00402-014-1958-z

Zhu Y YM, Meng HY, Way AY, Guo QY, Wang Y, Peng J. Basic science and clinical application of platelet-rich plasma for cartilage defects and osteoarthritis: a review. Osteoarthritis and Cartilage. 2013:1–11 https://doi.org/10.1016/j.joca.2013.07.017

Formby P, Pickett AM, Van Blarcum GS, Mack AW, Newman MT. The use of intravenous tranexamic acid in patients undergoing total hip or knee arthroplasty: a retrospective analysis at a single military institution. Mil Med. 2015;180(10):1087–90. https://doi.org/10.7205/MILMED-D-14-00657

Sabatini L, Atzori F, Revello S, Scotti L, Debiasi F, Massè A. Intravenous use of tranexamic acid reduces postoperative blood loss in total knee arthroplasty. Arch Orthop Trauma Surg. 2014;134(11):1609–14. https://doi.org/10.1007/s00402-014-2081-x

Basora M, Tió M, Martin M, Lozano L, Salazar F, Sánchez-Etayo G, et al. Should all patients be optimized to the same preoperative haemoglobin level to avoid transfusion in primary knee arthroplasty? Vox San. 2014;107(2):140–52. https://doi.org/10.1111/vox.12147

Wong J, Abrishami A, El Beheiry H, Mahomed NN, Roderick Davey J, Gandhi R, et al. Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial. J Bone Joint Surg Am. 2010;92(15):2503–14. https://doi.org/10.2106/JBJS.I.01518

Aguilera X, Martinez-Zapata MJ, Bosch A, Urrútia G, González JC, Jordan M, et al. Efficacy and safety of fibrin glue and tranexamic acid to prevent postoperative blood loss in total knee arthroplasty: a randomized controlled clinical trial. J Bone Joint Surg Am. 2013;95(22):2001–7. https://doi.org/10.2106/JBJS.L.01182

Panteli M, Papakostidis C, Dahabreh Z, Giannoudis PV. Topical tranexamic acid in total knee replacement: a systematic review and meta-analysis. Knee. 2013;20(5):300–9. https://doi.org/10.1016/j.knee.2013.05.014

Iwai T, Tsuji S, Tomita T, Sugamoto K, Hideki Y, Hamada M. Repeat-dose intravenous tranexamic acid further decreases blood loss in total knee arthroplasty. Int Orthop. 2013;37(3):441–5. https://doi.org/10.1007/s00264-013-1787-7

Wang H, Shen B, Zeng Y. Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials. Knee. 2014;21(6):987–93. https://doi.org/10.1016/j.knee.2014.09.010

Published

2017-01-25

How to Cite

1.
Triyudanto AN, Lubis AM. The effects of intra-articular tranexamic acid given intraoperatively and intravenous tranexamic acid given preoperatively on post surgical bleeding and transfusion rate post total knee arthroplasty. Med J Indones [Internet]. 2017Jan.25 [cited 2024Nov.21];25(4):234-9. Available from: http://mji.ui.ac.id/journal/index.php/mji/article/view/1502

Issue

Section

Clinical Research
Abstract viewed = 1566 times